Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Poland, Warsaw, Poland.
Department of Cardiology, Medical University of Bialystok, Poland, Bialystok, Poland.
Cardiol J. 2021;28(2):262-270. doi: 10.5603/CJ.a2019.0003. Epub 2019 Jan 30.
Anemia and vitamin D deficiency are common factors in chronic heart failure (CHF). The aim of this study was to assess vitamin D levels as well as its binding protein and anemia in relation to a cause of CHF: coronary heart disease, valvular disease and cardiomyopathy.
One hundred and sixteen consecutive patients (36 females and 80 males) with CHF were admitted for percutaneous coronary interventions (PCI). Hemoglobin concentration, serum creatinine, B-type natriuretic peptide (BNP), 25-hydroxyvitamin D [25(OH)D] and its binding protein-VDBP were measured.
The prevalence of anemia was 22%. BNP was the highest in the group with coronary artery disease. Ejection fraction was the lowest in cardiomyopathy group. 25(OH)D was lowest in valvular disease group, significantly lower than in the coronary artery group. A similar pattern of change showed vitamin D binding protein. The prevalence of vitamin D deficiency (level below 20 ng/mL) in the whole group was 95%, in 49% of the patients 25(OH)D was below 10 ng/mL. In univariate analysis 25(OH)D correlated with hemoglobin, red blood cell count, hematocrit, mean corpuscular volume and BNP in patients with CHF in the whole group. In multiple regression analysis, predictors of 25(OH)D were estimated, glomerular filtration rate, BNP and valvular disease.
25(OH)D deficiency is common in CHF patients. Valvular disease is associated the most severe vitamin D deficiency and worsened kidney function. A higher prevalence of anemia in CHF due to coronary heart disease may be associated with wider use of angiotensin converting enzyme inhibitors and acetylsalicylic acid. Heart and kidney function are predictors of 25(OH)D level in the patients of this study.
贫血和维生素 D 缺乏是慢性心力衰竭(CHF)的常见因素。本研究旨在评估维生素 D 水平及其结合蛋白与导致 CHF 的病因(冠心病、瓣膜病和心肌病)之间的关系。
116 例连续 CHF 患者(36 名女性和 80 名男性)因经皮冠状动脉介入治疗(PCI)入院。测量血红蛋白浓度、血清肌酐、B 型利钠肽(BNP)、25-羟维生素 D [25(OH)D]及其结合蛋白-VDBP。
贫血的患病率为 22%。在冠心病组中,BNP 最高。在心肌病组中,射血分数最低。瓣膜病组 25(OH)D 最低,明显低于冠状动脉组。维生素 D 结合蛋白也呈现出类似的变化模式。整个组中维生素 D 缺乏(水平低于 20ng/mL)的患病率为 95%,49%的患者 25(OH)D 低于 10ng/mL。在单变量分析中,25(OH)D 与血红蛋白、红细胞计数、血细胞比容、平均红细胞体积和 CHF 患者的 BNP 相关。在多元回归分析中,估计了 25(OH)D 的预测因子,肾小球滤过率、BNP 和瓣膜病。
25(OH)D 缺乏在 CHF 患者中很常见。瓣膜病与最严重的维生素 D 缺乏和肾功能恶化相关。由于冠心病导致的 CHF 中贫血的患病率较高,可能与更广泛使用血管紧张素转换酶抑制剂和乙酰水杨酸有关。心脏和肾脏功能是本研究患者 25(OH)D 水平的预测因子。